ACell Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 400

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $400M

ACell General Information

Description

Provider of extracellular matrix devices intended to leverage its platform technology to solve complex clinical problems in healing. The company manufactures products used in acute care settings as part of the treatment and management of wounds and reinforcement of soft tissue surgical defects.

Contact Information

Website
www.acell.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 6640 Eli Whitney Drive
  • Columbia, MD 21046
  • United States
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Acquirer
Integra Lifesciences
Corporate Office
  • 6640 Eli Whitney Drive
  • Columbia, MD 21046
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ACell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 20-Jan-2021 $400M Completed Profitable
5. IPO 28-Jul-2020 Cancelled Profitable
4. Debt - PPP 15-Apr-2020 Completed Generating Revenue
3. Later Stage VC (Series D) 22-Apr-2011 Completed Generating Revenue
2. Later Stage VC (Series C) 24-Dec-2008 $4.98M $7.98M Completed Generating Revenue
1. Early Stage VC (Series A) 25-Feb-2002 $3M $3M Completed Product Development
To view ACell’s complete valuation and funding history, request access »

ACell Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D
Series C
Series B 2,000,000 $0.001000 $3.27 $3.27 1x $1.09 17.61%
Series A 2,000,000 $0.001000 $1.5 $1.5 1x $1.5 5.87%
To view ACell’s complete cap table history, request access »

ACell Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of extracellular matrix devices intended to leverage its platform technology to solve complex clinical problems
Surgical Devices
Columbia, MD
400 As of 2020

Gaithersburg, MD
 

Malvern, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ACell Competitors (17)

One of ACell’s 17 competitors is Nuo Therapeutics, a Formerly VC-backed company based in Gaithersburg, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nuo Therapeutics Formerly VC-backed Gaithersburg, MD
TELA Bio Formerly VC-backed Malvern, PA
Reapplix Venture Capital-Backed Birkerod, Denmark
NuVasive Formerly VC-backed San Diego, CA
Mimedx Corporation Marietta, GA
You’re viewing 5 of 17 competitors. Get the full list »

ACell Patents

  • 186

    Total Documents Applications and Grants

  • Total Patents Families

  • 111

    Granted

  • 9

    Pending

  • Expiring in next 12 mo

ACell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3206678-A1 Medical graft devices and methods of making thereof Pending 29-Dec-2020
US-11826490-B1 Extracellular matrix sheet devices with improved mechanical properties and method of making Active 29-Dec-2020
EP-4271426-A1 Medical graft devices and methods of making thereof Pending 29-Dec-2020
US-20240316247-A1 Medical graft devices and methods of making thereof Pending 29-Dec-2020
US-20180280574-A1 Extracellular matrix compositions with bactericidal or bacteriostatic characteristics useful for protecting and treating patients with bacterial infections Inactive 31-Mar-2017 A61L27/3633
To view ACell’s complete patent history, request access »

ACell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ACell Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Haugo Corporation Minority
To view ACell’s complete investors history, request access »

Ready to get started?

Request a free trial

ACell FAQs

  • When was ACell founded?

    ACell was founded in 1999.

  • Where is ACell headquartered?

    ACell is headquartered in Columbia, MD.

  • What is the size of ACell?

    ACell has 400 total employees.

  • What industry is ACell in?

    ACell’s primary industry is Surgical Devices.

  • Is ACell a private or public company?

    ACell is a Private company.

  • What is the current valuation of ACell?

    The current valuation of ACell is .

  • What is ACell’s current revenue?

    The current revenue for ACell is .

  • How much funding has ACell raised over time?

    ACell has raised $16.7M.

  • Who are ACell’s investors?

    Haugo has invested in ACell.

  • Who are ACell’s competitors?

    Nuo Therapeutics, TELA Bio, Reapplix, NuVasive, and Mimedx are some of the 17 competitors of ACell.

  • When was ACell acquired?

    ACell was acquired on 20-Jan-2021.

  • Who acquired ACell?

    ACell was acquired by Integra Lifesciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »